Phase 2 trial of durvalumab and radiation revaccination in patients with metastatic adenocarcinoma of the pancreas who have progressed through first-line chemotherapy. Other Scholarly Work

cited authors

  • Chuong, Michael David; Badiyan, Shahed Nicolas; Mehta, Minesh P

authors

publication date

  • February 1, 2019

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

WoS ID

  • 000489107600015

Digital Object Identifier (DOI)

volume

  • 37

issue

  • 4